FGEN
Price
$0.57
Change
-$0.01 (-1.72%)
Updated
Jan 17 closing price
Capitalization
57.72M
44 days until earnings call
MIST
Price
$1.98
Change
+$0.02 (+1.02%)
Updated
Jan 17 closing price
Capitalization
105.59M
73 days until earnings call
Ad is loading...

FGEN vs MIST

Header iconFGEN vs MIST Comparison
Open Charts FGEN vs MISTBanner chart's image
FibroGen
Price$0.57
Change-$0.01 (-1.72%)
Volume$1.27M
Capitalization57.72M
Milestone Pharmaceuticals
Price$1.98
Change+$0.02 (+1.02%)
Volume$211.4K
Capitalization105.59M
FGEN vs MIST Comparison Chart
Loading...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGEN vs. MIST commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGEN is a Hold and MIST is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (FGEN: $0.57 vs. MIST: $1.98)
Brand notoriety: FGEN and MIST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGEN: 90% vs. MIST: 43%
Market capitalization -- FGEN: $57.72M vs. MIST: $105.59M
FGEN [@Biotechnology] is valued at $57.72M. MIST’s [@Biotechnology] market capitalization is $105.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGEN’s FA Score shows that 0 FA rating(s) are green whileMIST’s FA Score has 0 green FA rating(s).

  • FGEN’s FA Score: 0 green, 5 red.
  • MIST’s FA Score: 0 green, 5 red.
According to our system of comparison, both FGEN and MIST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FGEN’s TA Score shows that 4 TA indicator(s) are bullish while MIST’s TA Score has 2 bullish TA indicator(s).

  • FGEN’s TA Score: 4 bullish, 5 bearish.
  • MIST’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, FGEN is a better buy in the short-term than MIST.

Price Growth

FGEN (@Biotechnology) experienced а -7.01% price change this week, while MIST (@Biotechnology) price change was -4.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

FGEN is expected to report earnings on May 12, 2025.

MIST is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MIST($106M) has a higher market cap than FGEN($57.7M). FGEN YTD gains are higher at: 8.178 vs. MIST (-16.102). MIST has higher annual earnings (EBITDA): -39.14M vs. FGEN (-101.15M). FGEN has more cash in the bank: 131M vs. MIST (76.4M). MIST has less debt than FGEN: MIST (54M) vs FGEN (79.3M). FGEN has higher revenues than MIST: FGEN (180M) vs MIST (0).
FGENMISTFGEN / MIST
Capitalization57.7M106M54%
EBITDA-101.15M-39.14M258%
Gain YTD8.178-16.102-51%
P/E RatioN/AN/A-
Revenue180M0-
Total Cash131M76.4M171%
Total Debt79.3M54M147%
FUNDAMENTALS RATINGS
FGEN: Fundamental Ratings
FGEN
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
55
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FGENMIST
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
88%
Momentum
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
78%
MACD
ODDS (%)
Bullish Trend 5 days ago
80%
Bearish Trend 5 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 19 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
79%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

FGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGEN has been loosely correlated with AVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if FGEN jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGEN
1D Price
Change %
FGEN100%
-1.14%
AVTX - FGEN
57%
Loosely correlated
+0.30%
BEAM - FGEN
33%
Loosely correlated
+0.17%
PEPG - FGEN
31%
Poorly correlated
-4.96%
OVID - FGEN
30%
Poorly correlated
+1.37%
MIST - FGEN
29%
Poorly correlated
+1.02%
More

MIST and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIST has been loosely correlated with KRYS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MIST jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
+1.02%
KRYS - MIST
40%
Loosely correlated
+2.47%
CLDX - MIST
37%
Loosely correlated
+4.48%
MLTX - MIST
35%
Loosely correlated
+5.64%
BEAM - MIST
33%
Poorly correlated
+0.17%
RGNX - MIST
31%
Poorly correlated
+3.08%
More